DLA Troop Support is solicitating proposals for the suppyl of Zanamivir for Inhalation (Relenza). This acquisition is authorized under 10 USC 2304 (c) 1, Only One Responsible Source. The one responsible source being solicitated is GlaxoSmithKline, LLC. Approximately 629,187 PG are included in this requirement. A definite contract is proposed. Contractor shall deliver to various locations provided at time of award. Solicitation requests may be transmitted via email to [email protected] and by phone 215-737-4882.
Bid Protests Not Available
G